13
Participants
Start Date
November 30, 2016
Primary Completion Date
May 24, 2017
Study Completion Date
June 7, 2017
Insulin Lispro
Used to lower blood glucose. Commercially available by prescription and is indicated for patients with type 1 diabetes mellitus (T1DM), but not for use in a bionic pancreas. Individualized dose based on metabolic needs and frequent monitoring of blood glucose.
ZP4207 (dasiglucagon)
A glucagon analog not yet approved by the FDA. Subcutaneous administration in one BP arm.
Glucagon
A hormone normally made by the pancreas to raise blood glucose. Used to treat low blood sugar. Commercially available by prescription and is indicated for patients with T1DM in severe hypoglycemia, but not for use in a BP. Subcutaneous administration in one BP arm.
iPhone-based bionic pancreas
An experimental device.
iLet-based bionic pancreas
An experimental device.
MGH Diabetes Center, Boston
Lead Sponsor
Collaborators (1)
Massachusetts General Hospital
OTHER
Beta Bionics, Inc.
INDUSTRY
Zealand Pharma
INDUSTRY